everolimus
Not Tagged
['everolimus', 'rcc,(-irccs),(-srcc),(-urcc)', 'everest']
yesterday christopher ryan presented an update on the everest trial; adjuvant everolimus improved rfs in rcc, more pronounced in patients with high risk disease. there was a high discontinuation rate. session available on demand now as part of #asco22 
Independent and international experts in GenitoUrinary (GU) oncology. Part of https://t.co/QAbKORwRcf